{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:12:57Z","timestamp":1788462777278,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002966","name":"Sivas Cumhuriyet University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Schizophrenia is a chronic psychiatric disorder characterized by substantial biological and clinical heterogeneity. Beyond classical neurotransmitter-based models, increasing evidence suggests that systemic metabolic alterations may contribute to its pathophysiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to characterize urinary organic acid profiles in patients with schizophrenia and investigate their associations with clinical characteristics and pathway-level metabolic alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, urinary organic acids were quantified using liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) in 55 patients with schizophrenia and 30 age- and sex-matched healthy controls. Organic acid concentrations were normalized to urinary creatinine levels. Clinical severity was evaluated using the Positive and Negative Syndrome Scale and the Clinical Global Impressions\u2013Severity scale. Differential metabolite analysis, subgroup comparisons, principal component analysis, correlation analyses, and pathway enrichment analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with schizophrenia demonstrated widespread alterations in urinary organic acid profiles compared with healthy controls, with 40 metabolites remaining significantly different after false discovery rate correction. Subgroup analyses identified additional metabolomic variation according to symptom severity, treatment adherence, family history, and current treatment status. Principal component analysis demonstrated partial separation between patients and controls, whereas subgroup distributions showed substantial overlap. Correlation analyses revealed predominantly weak-to-moderate associations between clinical variables and urinary metabolite concentrations. Pathway enrichment analysis identified propanoate metabolism as the only pathway that remained statistically significant after multiple testing correction, while several additional pathways demonstrated nominal enrichment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that schizophrenia is associated with broad alterations in urinary metabolomic profiles and support the possibility that intermediary metabolic pathways may contribute to the biological complexity and heterogeneity of the disorder. Further longitudinal and validation studies are needed to clarify the biological and clinical relevance of these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11306-026-02479-5","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:48:45Z","timestamp":1781617725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary organic acid levels and their associations with clinical characteristics in patients with schizophrenia"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-5474","authenticated-orcid":false,"given":"Yavuz","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-0760","authenticated-orcid":false,"given":"Halef Okan","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-4175","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"Murat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-1835","authenticated-orcid":false,"given":"G\u00f6kmen","family":"Zarars\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"2","key":"2479_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-025-01550-9","volume":"40","author":"OL Adebayo","year":"2025","unstructured":"Adebayo, O. L., Luro, G. E., Akeju, I. D., Onu, C. F., Fawehinmi, M. E., Aderemi, V. A., & Atunnise, A. K. (2025). Sodium butyrate ameliorates mitochondrial oxidative stress and alterations in membrane-bound enzyme activities in pentylenetetrazole-induced kindling rat model. Metabolic Brain Disease, 40(2), Article 120. https:\/\/doi.org\/10.1007\/s11011-025-01550-9","journal-title":"Metabolic Brain Disease"},{"issue":"1","key":"2479_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/schbul\/sbq053","volume":"38","author":"VL Albaugh","year":"2012","unstructured":"Albaugh, V. L., Vary, T. C., Ilkayeva, O., Wenner, B. R., Maresca, K. P., Joyal, J. L., Breazeale, S., Elich, T. D., Lang, C. H., & Lynch, C. J. (2012). Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophrenia bulletin, 38(1), 153\u2013166. https:\/\/doi.org\/10.1093\/schbul\/sbq053","journal-title":"Schizophrenia bulletin"},{"issue":"1","key":"2479_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"1","key":"2479_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1192\/bjp.2024.239","volume":"227","author":"M Berk","year":"2025","unstructured":"Berk, M., Forbes, M., & Narayanaswamy, J. (2025). The history of biomarkers in psychiatry: Lessons learned, lessons forgotten, lessons rediscovered. The British journal of psychiatry: The journal of mental science, 227(1), 437\u2013438. https:\/\/doi.org\/10.1192\/bjp.2024.239","journal-title":"The British journal of psychiatry: The journal of mental science"},{"key":"2479_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2016.02.009","volume":"625","author":"MW Bourassa","year":"2016","unstructured":"Bourassa, M. W., Alim, I., Bultman, S. J., & Ratan, R. R. (2016). Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neuroscience letters, 625, 56\u201363. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.009","journal-title":"Neuroscience letters"},{"issue":"8","key":"2479_CR6","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1021\/pr300459d","volume":"11","author":"HL Cai","year":"2012","unstructured":"Cai, H. L., Li, H. D., Yan, X. Z., Sun, B., Zhang, Q., Yan, M., Zhang, W. Y., Jiang, P., Zhu, R. H., Liu, Y. P., Fang, P. F., Xu, P., Yuan, H. Y., Zhang, X. H., Hu, L., Yang, W., & Ye, H. S. (2012). Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-na\u00efve schizophrenia patients after treatment with risperidone. Journal of proteome research, 11(8), 4338\u20134350. https:\/\/doi.org\/10.1021\/pr300459d","journal-title":"Journal of proteome research"},{"key":"2479_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.schres.2019.03.009","volume":"226","author":"T Cao","year":"2020","unstructured":"Cao, T., Li, N., & Cai, H. (2020). Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist? Schizophrenia Research, 226, 95\u2013110. https:\/\/doi.org\/10.1016\/j.schres.2019.03.009","journal-title":"Schizophrenia Research"},{"key":"2479_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105745","volume":"176","author":"P Chakraborty","year":"2024","unstructured":"Chakraborty, P., Gamage, H. K. A. H., & Laird, A. S. (2024). Butyrate as a potential therapeutic agent for neurodegenerative disorders. Neurochemistry International, 176, Article 105745. https:\/\/doi.org\/10.1016\/j.neuint.2024.105745","journal-title":"Neurochemistry International"},{"issue":"4","key":"2479_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F., O\u2019Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., \u2026 Dinan, T. G. (2019). The Microbiota-Gut-Brain Axis. Physiological reviews, 99(4), 1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiological reviews"},{"issue":"8","key":"2479_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nature reviews. Gastroenterology & hepatology, 16(8), 461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nature reviews. Gastroenterology & hepatology"},{"issue":"1\u20133","key":"2479_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.schres.2007.10.003","volume":"98","author":"J de Leon","year":"2008","unstructured":"de Leon, J., Correa, J. C., Rua\u00f1o, G., Windemuth, A., Arranz, M. J., & Diaz, F. J. (2008). Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels. Schizophrenia research, 98(1\u20133), 40\u201346. https:\/\/doi.org\/10.1016\/j.schres.2007.10.003","journal-title":"Schizophrenia research"},{"issue":"2","key":"2479_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.c.30090","volume":"142C","author":"F Deodato","year":"2006","unstructured":"Deodato, F., Boenzi, S., Santorelli, F. M., & Dionisi-Vici, C. (2006). Methylmalonic and propionic aciduria. American journal of medical genetics Part C Seminars in medical genetics, 142C(2), 104\u2013112. https:\/\/doi.org\/10.1002\/ajmg.c.30090","journal-title":"American journal of medical genetics Part C Seminars in medical genetics"},{"key":"2479_CR13","volume-title":"Python 3: The comprehensive guide","author":"J Ernesti","year":"2025","unstructured":"Ernesti, J., & Kaiser, P. (2025). Python 3: The comprehensive guide. Packt Publishing."},{"key":"2479_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-83","volume":"11","author":"T Forkmann","year":"2011","unstructured":"Forkmann, T., Scherer, A., Boecker, M., Pawelzik, M., Jostes, R., & Gauggel, S. (2011). The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome. BMC psychiatry, 11, Article 83. https:\/\/doi.org\/10.1186\/1471-244X-11-83","journal-title":"BMC psychiatry"},{"key":"2479_CR15","volume-title":"ECDEU assessment manual for psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy, W. (1976). ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"issue":"7825","key":"2479_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R., Millman, K. J., Van Der Walt, S. J., Gommers, R., Virtanen, P., Cournapeau, D., Wieser, E., Taylor, J., Berg, S., Smith, N. J., & Kern, R. (2020). Array programming with NumPy. Nature, 585(7825), 357\u2013362. https:\/\/doi.org\/10.1038\/s41586-020-2649-2","journal-title":"Nature"},{"issue":"646","key":"2479_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn4772","volume":"14","author":"PE Head","year":"2022","unstructured":"Head, P. E., Myung, S., Chen, Y., Schneller, J. L., Wang, C., Duncan, N., Hoffman, P., Chang, D., Gebremariam, A., Gucek, M., Manoli, I., & Venditti, C. P. (2022). Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin. Science translational medicine, 14(646), Article eabn4772. https:\/\/doi.org\/10.1126\/scitranslmed.abn4772","journal-title":"Science translational medicine"},{"issue":"5","key":"2479_CR18","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","volume":"27","author":"ND Henkel","year":"2022","unstructured":"Henkel, N. D., Wu, X., O\u2019Donovan, S. M., Devine, E. A., Jiron, J. M., Rowland, L. M., Sarnyai, Z., Ramsey, A. J., Wen, Z., Hahn, M. K., & McCullumsmith, R. E. (2022). Schizophrenia: A disorder of broken brain bioenergetics. Molecular psychiatry, 27(5), 2393\u20132404. https:\/\/doi.org\/10.1038\/s41380-022-01494-x","journal-title":"Molecular psychiatry"},{"issue":"1","key":"2479_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","volume":"40","author":"M Huemer","year":"2017","unstructured":"Huemer, M., Diodato, D., Schwahn, B., Schiff, M., Bandeira, A., Benoist, J. F., Burlina, A., Cerone, R., Couce, M. L., Garcia-Cazorla, A., la Marca, G., Pasquini, E., Vilarinho, L., Weisfeld-Adams, J. D., Ko\u017eich, V., Blom, H., Baumgartner, M. R., & Dionisi-Vici, C. (2017). Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. Journal of Inherited Metabolic Disease, 40(1), 21\u201348. https:\/\/doi.org\/10.1007\/s10545-016-9991-4","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"2479_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/hmg\/ddi022","volume":"14","author":"K Iwamoto","year":"2005","unstructured":"Iwamoto, K., Bundo, M., & Kato, T. (2005). Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Human Molecular Genetics, 14(2), 241\u2013253. https:\/\/doi.org\/10.1093\/hmg\/ddi022","journal-title":"Human Molecular Genetics"},{"key":"2479_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107561","volume":"211","author":"S Kamath","year":"2025","unstructured":"Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., Marques, F. Z., & Joyce, P. (2025). IUPHAR themed review: The gut microbiome in schizophrenia. Pharmacological Research, 211, Article 107561. https:\/\/doi.org\/10.1016\/j.phrs.2024.107561","journal-title":"Pharmacological Research"},{"issue":"2","key":"2479_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin, 13(2), 261\u2013276. https:\/\/doi.org\/10.1093\/schbul\/13.2.261","journal-title":"Schizophrenia bulletin"},{"key":"2479_CR23","unstructured":"Kluyver, T., Ragan-Kelley, B., P\u00e9rez, F., Granger, B., Bussonnier, M., Frederic, J., & Kelley, K. (2016). Jupyter notebooks\u2014A publishing format for reproducible computational workflows. In Positioning and power in academic publishing: Players, agents and agendas: Proceedings of the 20th International Conference on Electronic Publishing (p. 87). IOS Press."},{"issue":"44","key":"2479_CR24","first-page":"23","volume":"14","author":"E Kostakoglu","year":"1999","unstructured":"Kostakoglu, E., Batur, S., Tiryaki, A., & Gogus, A. (1999). Reliability and validity of the Turkish version of the positive and negative syndrome scale (PANSS). Turk Psikoloji Dergisi, 14(44), 23\u201334.","journal-title":"Turk Psikoloji Dergisi"},{"key":"2479_CR25","unstructured":"LankyCyril (n.d.). Pyvenn [Computer software]. GitHub. https:\/\/github.com\/LankyCyril\/pyvenn"},{"issue":"12","key":"2479_CR26","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R., & Pfister, H. (2014). UpSet: Visualization of intersecting sets. IEEE Transactions on Visualization and Computer Graphics, 20(12), 1983\u20131992. https:\/\/doi.org\/10.1109\/TVCG.2014.2346248","journal-title":"IEEE Transactions on Visualization and Computer Graphics"},{"issue":"1","key":"2479_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73983-4","volume":"10","author":"R Li","year":"2020","unstructured":"Li, R., Zhang, Y., Zhu, W., Ding, C., Dai, W., Su, X., Dai, W., Xiao, J., Xing, Z., & Huang, X. (2020). Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: A systematic review and meta-analysis. Scientific Reports, 10(1), Article 17028. https:\/\/doi.org\/10.1038\/s41598-020-73983-4","journal-title":"Scientific Reports"},{"key":"2479_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymben.2022.05.007","volume":"73","author":"S Li","year":"2022","unstructured":"Li, S., Fu, W., Su, R., Zhao, Y., & Deng, Y. (2022). Metabolic engineering of the malonyl-CoA pathway to efficiently produce malonate in Saccharomyces cerevisiae. Metabolic Engineering, 73, 1\u201310. https:\/\/doi.org\/10.1016\/j.ymben.2022.05.007","journal-title":"Metabolic Engineering"},{"issue":"1","key":"2479_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89166-8","volume":"11","author":"S Li","year":"2021","unstructured":"Li, S., Song, J., Ke, P., Kong, L., Lei, B., Zhou, J., Huang, Y., Li, H., Li, G., Chen, J., Li, X., Xiang, Z., Ning, Y., Wu, F., & Wu, K. (2021). The gut microbiome is associated with brain structure and function in schizophrenia. Scientific Reports, 11(1), Article 9743. https:\/\/doi.org\/10.1038\/s41598-021-89166-8","journal-title":"Scientific Reports"},{"issue":"1","key":"2479_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu, H., Wang, J., He, T., Becker, S., Zhang, G., Li, D., & Ma, X. (2018). Butyrate: A Double-Edged Sword for Health? Advances in nutrition (Bethesda Md), 9(1), 21\u201329. https:\/\/doi.org\/10.1093\/advances\/nmx009","journal-title":"Advances in nutrition (Bethesda Md)"},{"issue":"2","key":"2479_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jimd.12478","volume":"45","author":"N Longo","year":"2022","unstructured":"Longo, N., Sass, J. O., Jurecka, A., & Vockley, J. (2022). Biomarkers for drug development in propionic and methylmalonic acidemias. Journal of inherited metabolic disease, 45(2), 132\u2013143. https:\/\/doi.org\/10.1002\/jimd.12478","journal-title":"Journal of inherited metabolic disease"},{"issue":"11","key":"2479_CR32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jpsychires.2008.11.006","volume":"43","author":"D Martins-de-Souza","year":"2009","unstructured":"Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi-Guly\u00e1s, E., Eberlin, M. N., Souza, G. H., Marangoni, S., Novello, J. C., Turck, C. W., & Dias-Neto, E. (2009). Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of psychiatric research, 43(11), 978\u2013986. https:\/\/doi.org\/10.1016\/j.jpsychires.2008.11.006","journal-title":"Journal of psychiatric research"},{"key":"2479_CR33","unstructured":"McKinney, W. (2015). Pandas: Python data analysis library. http:\/\/pandas.pydata.org"},{"issue":"11","key":"2479_CR34","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/jnr.24111","volume":"95","author":"F Mochel","year":"2017","unstructured":"Mochel, F. (2017). Triheptanoin for the treatment of brain energy deficit: A 14-year experience. Journal of Neuroscience Research, 95(11), 2236\u20132243. https:\/\/doi.org\/10.1002\/jnr.24111","journal-title":"Journal of Neuroscience Research"},{"issue":"5","key":"2479_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/schbul\/sbad049","volume":"49","author":"N Murray","year":"2023","unstructured":"Murray, N., Al Khalaf, S., Bastiaanssen, T. F. S., Kaulmann, D., Lonergan, E., Cryan, J. F., Clarke, G., Khashan, A. S., & O\u2019Connor, K. (2023). Compositional and functional alterations in intestinal microbiota in patients with psychosis or schizophrenia: A systematic review and meta-analysis. Schizophrenia Bulletin, 49(5), 1239\u20131255. https:\/\/doi.org\/10.1093\/schbul\/sbad049","journal-title":"Schizophrenia Bulletin"},{"issue":"1\u20132","key":"2479_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuint.2005.04.002","volume":"47","author":"P Ott","year":"2005","unstructured":"Ott, P., Clemmesen, O., & Larsen, F. S. (2005). Cerebral metabolic disturbances in the brain during acute liver failure: From hyperammonemia to energy failure and proteolysis. Neurochemistry International, 47(1\u20132), 13\u201318. https:\/\/doi.org\/10.1016\/j.neuint.2005.04.002","journal-title":"Neurochemistry International"},{"key":"2479_CR37","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Prettenhofer, P., Weiss, R., Dubourg, V., Vanderplas, J., Passos, A., Cournapeau, D., Brucher, M., Perrot, M., & Duchesnay, \u00c9. (2011). Scikit-learn: Machine learning in Python. Journal of Machine Learning Research, 12, 2825\u20132830.","journal-title":"Journal of Machine Learning Research"},{"issue":"7","key":"2479_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., Karp, N. A., Hester, S., Tkachev, D., Mimmack, M. L., Yolken, R. H., Webster, M. J., Torrey, E. F., & Bahn, S. (2004). Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry, 9(7), 684\u2013643. https:\/\/doi.org\/10.1038\/sj.mp.4001511","journal-title":"Molecular Psychiatry"},{"issue":"33","key":"2479_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh0558","volume":"9","author":"RH Purcell","year":"2023","unstructured":"Purcell, R. H., Sefik, E., Werner, E., King, A. T., Mosley, T. J., Merritt-Garza, M. E., Chopra, P., McEachin, Z. T., Karne, S., Raj, N., Vaglio, B. J., Sullivan, D., Firestein, B. L., Tilahun, K., Robinette, M. I., Warren, S. T., Wen, Z., Faundez, V., Sloan, S. A., \u2026 Mulle, J. G. (2023). Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Science Advances, 9(33), Article eadh0558. https:\/\/doi.org\/10.1126\/sciadv.adh0558","journal-title":"Science Advances"},{"key":"2479_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","volume":"56","author":"RC Roberts","year":"2021","unstructured":"Roberts, R. C. (2021). Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies. Mitochondrion, 56, 91\u2013101. https:\/\/doi.org\/10.1016\/j.mito.2020.11.009","journal-title":"Mitochondrion"},{"issue":"4","key":"2479_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jnc.12812","volume":"131","author":"U Sonnewald","year":"2014","unstructured":"Sonnewald, U. (2014). Glutamate synthesis has to be matched by its degradation - Where do all the carbons go? Journal of Neurochemistry, 131(4), 399\u2013406. https:\/\/doi.org\/10.1111\/jnc.12812","journal-title":"Journal of Neurochemistry"},{"key":"2479_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbi.2024.01.218","volume":"117","author":"M Stiernborg","year":"2024","unstructured":"Stiernborg, M., Prast-Nielsen, S., Melas, P. A., Skott, M., Millischer, V., Boulund, F., Forsell, Y., & Lavebratt, C. (2024). Differences in the gut microbiome of young adults with schizophrenia spectrum disorder: Using machine learning to distinguish cases from controls. Brain behavior and immunity, 117, 298\u2013309. https:\/\/doi.org\/10.1016\/j.bbi.2024.01.218","journal-title":"Brain behavior and immunity"},{"key":"2479_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fpsyt.2020.00156","volume":"11","author":"T Szeligowski","year":"2020","unstructured":"Szeligowski, T., Yun, A. L., Lennox, B. R., & Burnet, P. W. J. (2020). The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications. Frontiers in psychiatry, 11, 156. https:\/\/doi.org\/10.3389\/fpsyt.2020.00156","journal-title":"Frontiers in psychiatry"},{"key":"2479_CR44","volume-title":"Matplotlib for Python developers","author":"S Tosi","year":"2009","unstructured":"Tosi, S. (2009). Matplotlib for Python developers. Packt Publishing."},{"issue":"3","key":"2479_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., Van Der Walt, S. J., Brett, M., Wilson, J., Millman, K. J., Mayorov, N., Nelson, A. R. J., Jones, E., Kern, R., Larson, E., \u2026 SciPy 1.0 Contributors. (2020). SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nature Methods, 17(3), 261\u2013272. https:\/\/doi.org\/10.1038\/s41592-019-0686-2","journal-title":"Nature Methods"},{"issue":"60","key":"2479_CR46","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. (2021). seaborn: Statistical data visualization. Journal of Open Source Software, 6(60), 3021. https:\/\/doi.org\/10.21105\/joss.03021","journal-title":"Journal of Open Source Software"},{"issue":"1","key":"2479_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-013-3193-7","volume":"229","author":"H Yan","year":"2013","unstructured":"Yan, H., Chen, J. D., & Zheng, X. Y. (2013). Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology (Berl), 229(1), 1\u20137. https:\/\/doi.org\/10.1007\/s00213-013-3193-7","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"2479_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau8317","volume":"5","author":"P Zheng","year":"2019","unstructured":"Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., Zhou, X., Gui, S., Perry, S. W., Wong, M. L., Licinio, J., Wei, H., & Xie, P. (2019). The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Science advances, 5(2), Article eaau8317. https:\/\/doi.org\/10.1126\/sciadv.aau8317","journal-title":"Science advances"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02479-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:20:43Z","timestamp":1788459643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2479"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02479-5","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Incorrect affiliation of author G\u00f6kmen Zarars\u0131z has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Sivas Cumhuriyet University Ethical Committee (approval number: 2022-12\/08, dated December 13, 2022) and was conducted in accordance with the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used ChatGPT (OpenAI) solely to improve the clarity, fluency, and readability of the language. The AI tool was not used for data analysis, data interpretation, or the generation of scientific content. All AI-assisted text was carefully reviewed, edited, and verified by the authors, who take full responsibility for the content of the published article.","order":3,"name":"Ethics","label":"<b>Declaration of generative AI use<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"96"}}